The National Institute of Neurological Disorders and Stroke (NINDS), through its Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853), awarded Biocircuit Technologies Inc. (doing business as Axion PNI) a $1,887,020 Project Grant to support the commercialization of its Nerve Tape device for sutureless nerve repair. The Nerve Tape product consists of a flexible wrap with microscale hooks designed to easily align and hold together the ends of a severed nerve, providing a simple and reliable alternative to microsurgical suture techniques. The funding will enable Biocircuit to complete key steps for initial commercialization, including regulatory clearance for an updated device design, manufacturing process qualifications, and market launch preparations. This $1.9 million award will help advance Nerve Tape towards commercial availability to benefit patients with nerve injuries.
Generated 7/16/24, 9:01 AM